Improving quality of life measures for patients with ventricular tachycardia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates whether more frequent measurement of patient-reported outcome measures (PROMs), specifically health-related quality of life (HRQL), can enhance the assessment of clinical effectiveness and cost-effectiveness of catheter ablation for ventricular tachycardia (VT) in patients with an Implantable Cardioverter Defibrillator (ICD). It aims to determine the feasibility of regular HRQL monitoring to better capture the clinical narrative and quality of life changes in patients suffering from severe heart failure. The study will utilize validated quality of life questionnaires, such as EQ-5D and C-CAP, to gather data on patient experiences. Conducted at St Bartholomew's Hospital in London, it will involve patients identified through established referral pathways.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Adults (\>18 years) With an Implantable Cardioverter Defibrillator (ICD) implanted \>3 months from time of recruitment and a previous episode of documented VT requiring therapy from the ICD.

And impaired LV/RV function Willing and able to give written informed consent

Exclusion Criteria:

Patients who are planning to move away from study site within 12 months of enrolment who wished to use postal method to complete their HRQL Patients who are unable to give informed consent

Where it's running

• St Bartholomew's Hospital
  London, United Kingdom Recruiting

Study contacts

• Study coordinator: Yang Chen, BM BCh
• Email: yang.chen@nhs.net
• Phone: 02034165000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Observational study on patients with ventricular tachycardia and cardiomyopathy

  This study is tracking patients with heart muscle disease who experience fast heartbeats to see how well different treatments work and to help them live longer without heart problems.

  Recruiting at 3 sites Nova Scotia Health Authority · Vancouver, British Columbia and 2 other locations · NCT05835791

• AI-powered ECG to help diagnose and locate tachycardia in patients with PSVT, WPW, PVC, or VT

  A multicenter registry test whether an AI-enabled ECG analysis can help diagnose and localize tachycardia in adults with certain arrhythmias.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07859020

• DuoVT PFA System for Treating Ventricular Tachycardia

  This study tests whether the DuoVT Pulsed Field Ablation system can safely and effectively treat Ventricular Tachycardia in people with ischemic heart disease.

  Recruiting at 2 sites Abbott Medical Devices · Split, Dalmtia and 4 other locations · NCT07706712

• Sphere VT: Using Sphere-9 Catheter and Affera System to treat recurrent scar-related ventricular tachycardia

  This study tests the Sphere-9 catheter and Affera mapping and ablation system in adults with recurring scar-related ventricular tachycardia after a prior heart attack.

  Recruiting at 5 sites Medtronic Cardiac Ablation Solutions · Littleton, Colorado and 6 other locations · NCT07585968

• Left bundle branch pacing plus ICD for people with hypertrophic cardiomyopathy after myectomy

  This study will test whether adding left bundle branch pacing to a dual‑chamber ICD helps people with hypertrophic cardiomyopathy who develop left bundle branch block after myectomy to slow heart failure progression and prevent life‑threatening arrhythmias.

  Recruiting Meshalkin Research Institute of Pathology of Circulation · Novosibirsk, Novosibirsk Oblast · NCT07372196

• Lead-related tricuspid valve leakage after first-time pacemaker or ICD implantation

  This project will see if a new transvenous pacemaker or ICD lead causes new or worse tricuspid valve regurgitation in people getting their first device.

  Recruiting Clinic for General and Interventional Cardiology/Angiology, Herz- und Diabeteszentrum NRW · Bad Oeynhausen, North Rhine-Westphalia · NCT07342036

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.